Soleus Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-85,000	Closed	-$4.35M	–	78
2024 Q4	$4.35M	Buy	+85,000	New	+$4.35M	0.27%	55